(Q52925796)

English

Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.

scientific article published in September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

1 reference

based on heuristic

inferred from title

author name string

D K Heyland

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

A Gafni

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

M A Levine

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

Journal of Clinical Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

53

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

9

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

888-894

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolytic agents: the science of the art of choosing the better treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical decision making: from theory to practice. Anatomy of a decision

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporating patients' preferences into medical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast irradiation postlumpectomy: development and evaluation of a decision instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient preferences for thrombolytic therapy in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Health States Worse than Death

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Choice Under Uncertainty: Problems Solved and Unsolved

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Judgment under Uncertainty: Heuristics and Biases

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospect Theory: An Analysis of Decision under Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0895-4356(99)00214-0

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11004415

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52925796&oldid=1577676312"